Showing results (81-90 of 210) with videos related to

Sort By:
Pageof 21
Journal of Atherosclerosis and Thrombosis|February 9, 2025
Long-Term Effects of Extended-Release Pemafibrate Tablets on Dyslipidemia and Safety in Triglyceridemic Patients: A Phase 3, Multicenter, Randomized, Open-Label, Parallel-Group StudyHidenori Arai, Shizuya Yamashita, Eiichi Araki, et al.
Diabetes Research and Clinical Practice|March 7, 2002
Sudden onset of diabetes with ketoacidosis in a patient treated with FK506/tacrolimusTetsushi Toyonaga, Tatsuya Kondo, Nobuhiro Miyamura, et al.
Internal Medicine (Tokyo, Japan)|April 8, 2010
Plasma renin activity and aldosterone concentration are not altered by the novel calcium channel antagonist, azelnidipine, in hypertensive patientsTatsuya Kondo, Rieko Goto, Kazuhiro Sonoda, et al.
Journal of Diabetes and Its Complications|June 15, 2017
Impaired balance is related to the progression of diabetic complications in both young and older adultsDaisuke Kukidome, Takeshi Nishikawa, Miki Sato, et al.
The Journal of Clinical Endocrinology and Metabolism|February 8, 2003
Atypical Bartter syndrome with sensorineural deafness with G47R mutation of the beta-subunit for ClC-Ka and ClC-Kb chloride channels, barttinNobuhiro Miyamura, Kazuya Matsumoto, Tetsuya Taguchi, et al.
Diabetology International|February 26, 2019
Correction to: Japanese Clinical Practice Guideline for Diabetes 2016Masakazu Haneda, Mitsuhiko Noda, Hideki Origasa, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|July 15, 2022
Clinical Benefit of Switching from Low-Dose to High-Dose Empagliflozin in Patients with Type 2 DiabetesTakeshi Matsumura, Tomoko Makabe, Seiko Ueda, et al.
Journal of Atherosclerosis and Thrombosis|September 25, 2024
Clinical Pharmacology of Pemafibrate Extended-release Formulation in Patients with Hypertriglyceridemia-A Phase 2, Multicenter, Active-controlled, Randomized, Single-blind, Crossover studyShizuya Yamashita, Eiichi Araki, Hidenori Arai, et al.
International Journal of Molecular Sciences|February 10, 2019
Long-Term Efficacy and Safety of Pemafibrate, a Novel Selective Peroxisome Proliferator-Activated Receptor-α Modulator (SPPARMα), in Dyslipidemic Patients with Renal ImpairmentKoutaro Yokote, Shizuya Yamashita, Hidenori Arai, et al.
Internal Medicine (Tokyo, Japan)|February 16, 2012
A case of cortisol producing adrenal adenoma associated with a latent aldosteronoma: usefulness of the ACTH loading test for the detection of covert aldosteronism in overt Cushing syndromeDaisuke Kukidome, Nobuhiro Miyamura, Kourin Sakakida, et al.
Pageof 21